Health Technology Net

Xenetic Biosciences, Inc. (NASDAQ: XBIO) Announces Agreement to Acquire Innovative CAR T Technology Platform

user March 4, 2019

Innovative XCART platform with demonstrated proof of mechanism and preclinical evidence of target specificity positions Xenetic to address high value...

Savara to Present at the 39th Annual Cowen and Company Healthcare Conference

user March 4, 2019

AUSTIN, TX / ACCESSWIRE / March 4, 2019 / Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, announced today...

Soliton Receives FDA Approval for Small Business Designation

user March 4, 2019

The Company qualifies for reduced or waived fees for medical device submissions with the FDA HOUSTON, TX / ACCESSWIRE /...

Theralase Granted United States Patent to Destroy Cancer Cells with X-Ray Activated Photo Dynamic Compounds

user March 4, 2019

TORONTO, ONTRAIO / ACCESSWIRE / March 4, 2019 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),...

Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER

user March 4, 2019

TORONTO, ON / ACCESSWIRE / March 4, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) ("Intellipharmaceutics" or the "Company"),...

Avinger to Present at Oppenheimer Healthcare Conference on March 20

user March 2, 2019

REDWOOD CITY, CA / ACCESSWIRE / March 1, 2019 / Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments...

EyeGate Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Business Update

user March 2, 2019

WALTHAM, MA / ACCESSWIRE / March 1, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (''EyeGate'' or ''the Company'') today announced...

ITOCO – Camedco JV Creates Future Leader in Medical Cannabis

user March 2, 2019

TORONTO, ON / ACCESSWIRE / February 27, 2019 / Itoco Inc (OTC PINK: ITMC), has signed a letter of intent...

Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium

user March 2, 2019

- Preliminary data suggests the addition of HS-110 to Nivolumab may restore responsiveness to treatment after tumor progression on prior...

New Paper Relevant for the Optimal Development of Drugs Targeting LSD1 Published by ORYZON

user March 2, 2019

Uses proprietary chemoprobe technology to demonstrate target engagement, key to drug development and rational dosing Useful to identify interaction partners...

Evotec Receives Milestone Payment For Start Of Second Phase II Trial In Its Multi-Target Alliance With Bayer

user March 2, 2019

PHASE II CLINICAL TRIAL ON PERSISTENT CHRONIC COUGH HAMBURG, GERMANY / ACCESSWIRE / February 28, 2019 / Evotec AG (OTC...

Theralase Named to 2019 TSX Venture 50(TM)

user March 2, 2019

Theralase Achieves Third Place in the Clean Technology and Life Sciences Category on the 2019 TSX Venture 50 TM TORONTO,...

EviTrade Provides Update on Hemp Based Extraction and Processing Facility

user March 2, 2019

VANCOUVER, BC / ACCESSWIRE / February 28, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the ''Company'') provides...

Meet IKU DAO: The Company Prioritizing Drug Discovery By The Consumers

user March 2, 2019

DALLAS, TX / ACCESSWIRE / February 26, 2019 / What if there was a way to prioritize drug discovery by...

MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis

user March 2, 2019

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / February 27, 2019 / MorphoSys AG (FSE: MOR) (NASDAQ: MOR) announced today that...

Health Technology Net

Did You Know?

How To Make Use Of Medicare And Medicaid If You Are Diabetic

Revolutionizing Prescription Management: Simplify Your To-Do List

Having Trouble Scheduling a Doctor’s Appointment?

3 Strategies to Make Your Medical Practice Inclusive for Underserved Communities

Navigating the Intersection of Social Media and Youth Mental Health: A Call to Action for Pediatricians

Editor’s Picks

$35 Insulin: How The Program Came To Be, Who Did It And How Can You Use It?

“Each State’s Medicaid Program Reflects the Unique Needs of its Population, Making the One-Size-Fits-All 80/20 Rule Problematic:” Aaron Marcum’s Standpoint on the Challenges of Healthcare Reform

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease

Next Health Announces Proactive Healthcare and Longevity Centers Coming Soon to Tampa and St. Petersburg

Quantum Biopharma Provides Corporate Update

Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease

Xenetic Biosciences, Inc. (NASDAQ: XBIO) Announces Agreement to Acquire Innovative CAR T Technology Platform

Savara to Present at the 39th Annual Cowen and Company Healthcare Conference

Soliton Receives FDA Approval for Small Business Designation

Theralase Granted United States Patent to Destroy Cancer Cells with X-Ray Activated Photo Dynamic Compounds

Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER

Avinger to Present at Oppenheimer Healthcare Conference on March 20

EyeGate Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Business Update

ITOCO – Camedco JV Creates Future Leader in Medical Cannabis

Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium

New Paper Relevant for the Optimal Development of Drugs Targeting LSD1 Published by ORYZON

Evotec Receives Milestone Payment For Start Of Second Phase II Trial In Its Multi-Target Alliance With Bayer

Theralase Named to 2019 TSX Venture 50(TM)

EviTrade Provides Update on Hemp Based Extraction and Processing Facility

Meet IKU DAO: The Company Prioritizing Drug Discovery By The Consumers

MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis

Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR

Sohm, Inc., Announces Shares Buyback Program

People Unlimited to Present on Ageless Prosperity

Eviana Announces Deal to Sell 155 Metric Tonnes of Industrial Hemp to International Cannabis Corp.

International Cannabrands Announces New Appointments to Board and Management

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease

Next Health Announces Proactive Healthcare and Longevity Centers Coming Soon to Tampa and St. Petersburg

Quantum Biopharma Provides Corporate Update

Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease

Did You Know?

Editor’s Picks

Latest News

Fresh Off The press

You may have missed